| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Centre for Biochemical Pharmacology,* William Harvey Research Institute, London, United Kingdom; the Post-Graduation in Morphology, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; and the Department of Biology, Instituto de Biociências, Letras e Ciências Exatas (IBILCE), Universidade do Estado de São Paulo (UNESP), São José do Rio Preto, São Paulo, Brazil
The inflammatory response is a protective process of the body to counteract xenobiotic penetration and injury, although in disease this response can become deregulated. There are endogenous biochemical pathways that operate in the host to keep inflammation under control. Here we demonstrate that the counterregulator annexin 1 (AnxA1) is critical for controlling experimental endotoxemia. Lipopolysaccharide (LPS) markedly activated the AnxA1 gene in epithelial cells, neutrophils, and peritoneal, mesenteric, and alveolar macrophages—cell types known to function in ex-perimental endotoxemia. Administration of LPS to AnxA1-deficient mice produced a toxic response characterized by organ injury and lethality within 48 hours, a phenotype rescued by exogenous application of low doses of the protein. In the absence of AnxA1, LPS generated a deregulated cellular and cytokine response with a marked degree of leukocyte adhesion in the microcirculation. Analysis of LPS receptor expression in AnxA1-null macrophages indicated an aberrant expression of Toll-like receptor 4. In conclusion, this study has detailed cellular and biochemical alterations associated with AnxA1 gene deletion and highlighted the impact of this protective circuit for the correct functioning of the homeostatic response to sublethal doses of LPS.
This article has been cited by other articles:
 |
|
 |
|
  F. N. E. Gavins, J. Dalli, R. J. Flower, D. N. Granger, and M. Perretti Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation FASEB J, June 1, 2007; 21(8): 1751 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. H. Yang, M.-L. Toh, C. D. Clyne, M. Leech, D. Aeberli, J. Xue, A. Dacumos, L. Sharma, and E. F. Morand Annexin 1 Negatively Regulates IL-6 Expression via Effects on p38 MAPK and MAPK Phosphatase-1 J. Immunol., December 1, 2006; 177(11): 8148 - 8153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Warne, C. D. John, H. C. Christian, J. F. Morris, R. J. Flower, D. Sugden, E. Solito, G. E. Gillies, and J. C. Buckingham Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1264 - E1273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Damazo, S. Yona, R. J. Flower, M. Perretti, and S. M. Oliani Spatial and Temporal Profiles for Anti-Inflammatory Gene Expression in Leukocytes during a Resolving Model of Peritonitis J. Immunol., April 1, 2006; 176(7): 4410 - 4418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. G. Hayhoe, A. M. Kamal, E. Solito, R. J. Flower, D. Cooper, and M. Perretti Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement Blood, March 1, 2006; 107(5): 2123 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Babbin and A. T. Gewirtz A Most Important Annexation Am. J. Pathol., June 1, 2005; 166(6): 1581 - 1583. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
